FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2936953054> ?p ?o ?g. }

• W2936953054 endingPage "347" @default.
• W2936953054 startingPage "335" @default.
• W2936953054 abstract "Human epidermal growth factor receptor 2 (HER2) is an oncogenic driver, and a well-established therapeutic target in breast and gastric cancers. While the role of HER2 as a prognostic biomarker in colorectal adenocarcinomas (CRCs) remains uncertain, its relevance as a therapeutic target has been established. We undertook the present study to evaluate the frequency of HER2 expression in CRC and to correlate it with various clinicopathological variables.To correlate HER2 protein expression and HER2 gene amplification with clinicopathological features and survival in surgically resected CRC.About 1195 consecutive surgically resected CRCs were analyzed by immunohistochemical staining (IHC) to assess HER2 protein expression, and 141 selected tumors were further evaluated by fluorescence in situ hybridization (FISH) to assess HER2 gene amplification. Follow-up information was available for 1058 patients, and using this information we investigated the prevalence of HER2 protein overexpression and gene amplification in a large series of surgically resected CRCs, and evaluated the relationship between overexpression and clinicopathological parameters and prognosis.HER2 IHC scores of 3+, 2+, 1+, and 0 were seen in 31 (2.6%), 105 (8.8%), 475 (39.7%), and 584 (48.9%) tumors, respectively. HER2 gene amplification was seen in 24/29 tumors with an IHC score of 3+ (82.8%; unreadable in 2/31), 12/102 tumors with an IHC score of 2+ (11.8%; unreadable in 2/104), and 0 tumors with IHC score of 1+ (0/10). HER2 gene amplification was seen in 36/1191 tumors (3.0%; unreadable in 4/1195). Among the tumors with HER2 IHC scores of 3+ and 2+, the mean percentage of tumor cells with positive IHC staining was 90% (median 100%, range 40%-100%) and 67% (median 75%, range 5%-95%), respectively (P < 0.05). Among tumors with IHC scores of 2+, those with HER2 gene amplification had a higher number of tumors cells with positive IHC staining (n = 12, mean 93%, median 95%, range 90%-95%) than those without (n = 90, mean 70%, median 50%, range 5%-95%) (P < 0.05). HER2 gene status was significantly associated with distant tumor metastasis and stage (P = 0.028 and 0.025). HER2 protein overexpression as measured by IHC or HER2 gene amplification as measured by FISH was not associated with overall survival (OS) or disease-specific survival for the overall group of 1058 patients. However, further stratification revealed that among patients with tubular adenocarcinomas who were 65 years old or younger (n = 601), those exhibiting HER2 gene amplification had a shorter OS than those without (mean: 47.9 mo vs 65.1 mo, P = 0.04). Among those patients with moderately to poorly differentiated tubular adenocarcinomas, those with positive HER2 tumor IHC scores (2+, 3+) had a shorter mean OS than those with negative HER2 IHC scores (0, 1+) (47.2 mo vs 64.8 mo, P = 0.033). Moreover, among patients with T2 to T4 stage tumors, those with positive HER2 IHC scores also had a shorter mean OS than those with negative HER2 IHC scores (47.1 mo vs 64.8 mo, P = 0.031).HER2 protein levels are correlated with clinical outcomes, and positive HER2 expression as measured by IHC confers a worse prognosis in those patients 65 years old or younger with tubular adenocarcinomas." @default.
• W2936953054 created "2019-04-25" @default.
• W2936953054 creator A5016518215 @default.
• W2936953054 creator A5022036531 @default.
• W2936953054 creator A5042320112 @default.
• W2936953054 creator A5057701440 @default.
• W2936953054 creator A5059604998 @default.
• W2936953054 creator A5061483988 @default.
• W2936953054 creator A5062071538 @default.
• W2936953054 creator A5081744672 @default.
• W2936953054 creator A5087244383 @default.
• W2936953054 date "2019-04-15" @default.
• W2936953054 modified "2023-09-26" @default.
• W2936953054 title "Significance of HER2 protein expression and <i>HER2</i> gene amplification in colorectal adenocarcinomas" @default.
• W2936953054 cites W1800916217 @default.
• W2936953054 cites W1838685504 @default.
• W2936953054 cites W1965427258 @default.
• W2936953054 cites W1968881689 @default.
• W2936953054 cites W1979488703 @default.
• W2936953054 cites W1987009448 @default.
• W2936953054 cites W1988696372 @default.
• W2936953054 cites W2000028774 @default.
• W2936953054 cites W2021501684 @default.
• W2936953054 cites W2030807319 @default.
• W2936953054 cites W2040935952 @default.
• W2936953054 cites W2041260399 @default.
• W2936953054 cites W2043103956 @default.
• W2936953054 cites W2043711125 @default.
• W2936953054 cites W2046073869 @default.
• W2936953054 cites W2059893505 @default.
• W2936953054 cites W2060479298 @default.
• W2936953054 cites W2062335278 @default.
• W2936953054 cites W2073892530 @default.
• W2936953054 cites W2075657881 @default.
• W2936953054 cites W2097988373 @default.
• W2936953054 cites W2099954087 @default.
• W2936953054 cites W2100439220 @default.
• W2936953054 cites W2100716241 @default.
• W2936953054 cites W2112807374 @default.
• W2936953054 cites W2117482026 @default.
• W2936953054 cites W2125620887 @default.
• W2936953054 cites W2126816162 @default.
• W2936953054 cites W2141393790 @default.
• W2936953054 cites W2147674085 @default.
• W2936953054 cites W2149908785 @default.
• W2936953054 cites W2156544288 @default.
• W2936953054 cites W2760130725 @default.
• W2936953054 cites W2770347143 @default.
• W2936953054 doi "https://doi.org/10.4251/wjgo.v11.i4.335" @default.
• W2936953054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6475672" @default.
• W2936953054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31040898" @default.
• W2936953054 hasPublicationYear "2019" @default.
• W2936953054 type Work @default.
• W2936953054 sameAs 2936953054 @default.
• W2936953054 citedByCount "22" @default.
• W2936953054 countsByYear W29369530542019 @default.
• W2936953054 countsByYear W29369530542020 @default.
• W2936953054 countsByYear W29369530542021 @default.
• W2936953054 countsByYear W29369530542022 @default.
• W2936953054 countsByYear W29369530542023 @default.
• W2936953054 crossrefType "journal-article" @default.
• W2936953054 hasAuthorship W2936953054A5016518215 @default.
• W2936953054 hasAuthorship W2936953054A5022036531 @default.
• W2936953054 hasAuthorship W2936953054A5042320112 @default.
• W2936953054 hasAuthorship W2936953054A5057701440 @default.
• W2936953054 hasAuthorship W2936953054A5059604998 @default.
• W2936953054 hasAuthorship W2936953054A5061483988 @default.
• W2936953054 hasAuthorship W2936953054A5062071538 @default.
• W2936953054 hasAuthorship W2936953054A5081744672 @default.
• W2936953054 hasAuthorship W2936953054A5087244383 @default.
• W2936953054 hasBestOaLocation W29369530541 @default.
• W2936953054 hasConcept C104317684 @default.
• W2936953054 hasConcept C121608353 @default.
• W2936953054 hasConcept C126322002 @default.
• W2936953054 hasConcept C142724271 @default.
• W2936953054 hasConcept C143998085 @default.
• W2936953054 hasConcept C204232928 @default.
• W2936953054 hasConcept C2777542201 @default.
• W2936953054 hasConcept C2779786085 @default.
• W2936953054 hasConcept C2781197716 @default.
• W2936953054 hasConcept C2908728163 @default.
• W2936953054 hasConcept C30481170 @default.
• W2936953054 hasConcept C502942594 @default.
• W2936953054 hasConcept C526805850 @default.
• W2936953054 hasConcept C530470458 @default.
• W2936953054 hasConcept C55493867 @default.
• W2936953054 hasConcept C63363279 @default.
• W2936953054 hasConcept C71924100 @default.
• W2936953054 hasConcept C7602840 @default.
• W2936953054 hasConcept C86803240 @default.
• W2936953054 hasConceptScore W2936953054C104317684 @default.
• W2936953054 hasConceptScore W2936953054C121608353 @default.
• W2936953054 hasConceptScore W2936953054C126322002 @default.
• W2936953054 hasConceptScore W2936953054C142724271 @default.
• W2936953054 hasConceptScore W2936953054C143998085 @default.
• W2936953054 hasConceptScore W2936953054C204232928 @default.
• W2936953054 hasConceptScore W2936953054C2777542201 @default.
• W2936953054 hasConceptScore W2936953054C2779786085 @default.

• next